Results 61 to 70 of about 13,064 (207)
Abstract Background Extracellular vesicles (EVs), especially exosomes, are nanoparticles increasingly recognized as key regulators of intercellular communication in both physiological and pathological aspects. Despite rapid progress, inconsistencies in nomenclature, isolation, and characterization continue to restrict translational advancement.
Paras Ahmad +6 more
wiley +1 more source
EPHA2 degradation is mediated by proteasomal pathway.
(A) Mutant EPHA2 proteins have a reduced half-life. HEK293T cells were treated for indicated time with the protein biosynthesis inhibitor CHX (50 µg/mL) or the proteasome inhibitor MG132 (10 µM).
Alexander I. Son (166874) +5 more
core +1 more source
Abstract figure legend LIGHT is a mutual mediator of intestinal and oesophageal fibroblast inflammation with common as well as tissue‐specific effects. Hydroxylase inhibitors can selectively suppress inflammatory factors in both cell types, albeit targeting different signalling pathways.
Cian M. Ohlendieck +13 more
wiley +1 more source
Evidence that the EphA2 receptor exacerbates ischemic brain injury. [PDF]
Ephrin (Eph) signaling within the central nervous system is known to modulate axon guidance, synaptic plasticity, and to promote long-term potentiation.
Dale Pavlovski +41 more
core +1 more source
Abstract Aim Liquid biopsy is minimally invasive (compared with tissue biopsy) and has previously been used to generate systems data regarding drug elimination via hepatic enzymes and transporters. This study extends quantitative assessment of systems parameters in liquid biopsy to pharmacodynamic (PD) and disease markers relevant to cancer development
Zubida M. Al‐Majdoub +3 more
wiley +1 more source
Neutrophils: Heterogeneity, Biology, Diseases, and Therapeutic Strategies
Neutrophils exhibit remarkable functional plasticity and play dual roles in tissue protection and disease progression. This review summarizes their key biological functions and highlights the shift from conventional broad‐spectrum interventions to neutrophil‐based drug delivery systems.
Yibing Zhang +4 more
wiley +1 more source
Review on EPHA2 (EPH receptor A2), with data on DNA, on the protein encoded, and where the gene is implicated.
Gatzidou, ET, Theocharis, S, Giaginis, C
openaire +2 more sources
EPHA2, a promising therapeutic target for hepatocellular carcinoma
Identifying critical drivers of oncogenesis and tumor progression is essential for developing effective hepatocellular carcinoma (HCC) therapeutics. Our recent findings has demonstrated that targeting Ephrin Receptor A2 (EPHA2) suppresses HCC initiation ...
Hao Wang, Wei Qiu
doaj +1 more source
Biomimetic Scaffold‐Based 3D Models for Decoding Cancer Biology and Advancing Therapy
A timeline of the research history of 3D biomimetic scaffold materials and platforms. With advances in biomimetic materials and 3D scaffold technologies, their functional scope has expanded from mimicking basic physical and biochemical properties to increasingly replicating complex pathophysiological processes.
Haitao Zhao +10 more
wiley +1 more source
EphA2 receptor expression in hepatocytic cell lines.
A. Hepa1-6 cells were stained with anti-EphA2 D4A2 (blue, left panel) or anti-CD81 MT81 (blue, right panel) followed by Alexa Fluor-488 conjugated secondary antibodies, and analyzed by FACS.
Anne-Claire Langlois (5485085) +3 more
core +1 more source

